抗組織型纖溶酶原激活因子(tPA)單克隆抗體
Anti-Tissue Plasminogen Activator (tPA) Monoclonal Antibody
PLAT; T-PA; t-plasminogen activator; Alteplase; Reteplase
- 編號(hào)UFAA525Hu08
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 效價(jià)L8
- Ig亞型 IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物無標(biāo)記物
- 激發(fā)波長
- 單次使用量
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 且適物種-
- 應(yīng)用FCM
- 下載 英文說明書 中文說明書
- 規(guī)格 25test50test 100test 200test 500test
- 價(jià)格 ¥ 360 ¥ 600 ¥ 960 ¥ 1200 ¥ 2100
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Human U2OS cell line was fixed with 2% paraformaldehyde (10 min) , permeabilised with 0.1% BSA-Triton X-100,then stained with 10μg/ml mouse Anti-human tPA Monoclonal Antibody (Catalog FAA525Hu08, red histogram) or Isotype control antibody (Catalog IS067-Mu01, green histogram), followed by 1μg/ml FITC-conjugated Anti-mouse IgG Secondary Antibody (Catalog SAA544Mu18).
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
用法
Flow cytometry: 10μg/ml;
Optimal working dilutions must be determined by end user.
儲(chǔ)存
經(jīng)常使用則4°C保存。-20°C保存不超過一年。避免反復(fù)凍融。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| URPA525Hu04 | 組織型纖溶酶原激活因子(tPA)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPA525Hu05 | 組織型纖溶酶原激活因子(tPA)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPA525Hu06 | 組織型纖溶酶原激活因子(tPA)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPA525Hu02 | 組織型纖溶酶原激活因子(tPA)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UEPA525Hu62 | 組織型纖溶酶原激活因子(tPA)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPA525Hu01 | 組織型纖溶酶原激活因子(tPA)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPA525Hu03 | 組織型纖溶酶原激活因子(tPA)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UAPA525Hu61 | 組織型纖溶酶原激活因子(tPA)活性蛋白 | Cell?culture;?Activity?Assays. |
| UAPA525Hu62 | 組織型纖溶酶原激活因子(tPA)活性蛋白 | Cell?culture;?Activity?Assays. |
| UEPA525Hu61 | 組織型纖溶酶原激活因子(tPA)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAA525Hu01 | 組織型纖溶酶原激活因子(tPA)多克隆抗體 | IHC |
| UPAA525Hu02 | 組織型纖溶酶原激活因子(tPA)多克隆抗體 | WB; IHC |
| UFAA525Hu01 | 抗組織型纖溶酶原激活因子(tPA)多克隆抗體 | FCM |
| UMAA525Hu22 | 組織型纖溶酶原激活因子(tPA)單克隆抗體 | WB; ICC/IF |
| UMAA525Hu24 | 組織型纖溶酶原激活因子(tPA)單克隆抗體 | IHC |
| UMAA525Hu26 | 組織型纖溶酶原激活因子(tPA)單克隆抗體 | WB |
| UMAA525Hu23 | 組織型纖溶酶原激活因子(tPA)單克隆抗體 | WB |
| UMAA525Hu21 | 組織型纖溶酶原激活因子(tPA)單克隆抗體 | WB |
| UMAA525Hu28 | 組織型纖溶酶原激活因子(tPA)單克隆抗體 | ICC/IF |
| UMAA525Hu25 | 組織型纖溶酶原激活因子(tPA)單克隆抗體 | ICC/IF |
| UMAA525Hu27 | 組織型纖溶酶原激活因子(tPA)單克隆抗體 | ICC/IF |
| UMAA525Hu29 | 組織型纖溶酶原激活因子(tPA)單克隆抗體 | ICC/IF |
| UFAA525Hu08 | 抗組織型纖溶酶原激活因子(tPA)單克隆抗體 | FCM |
| UFAA525Hu02 | 抗組織型纖溶酶原激活因子(tPA)單克隆抗體 | FCM |
| UFAA525Hu04 | 抗組織型纖溶酶原激活因子(tPA)單克隆抗體 | FCM |
| UFAA525Hu06 | 抗組織型纖溶酶原激活因子(tPA)單克隆抗體 | FCM |
| USEA525Hu | 組織型纖溶酶原激活因子(tPA)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| ULMA525Hu | 組織型纖溶酶原激活因子(tPA)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Annals of Clinical & Laboratory Science | Alteration of Hemostatic Parameters in Patients with Different Levels of Subclinical Hypothyroidism and the Effect of L-thyroxine Treatment [pubmed:28249913] |
| Cellular Physiology and Biochemistry | Defective Platelet Activation and Bleeding Complications upon Cholestasis in Mice [pubmed:28441661] |
| Journal of allergy and clinical immunology | Cytokine and estrogen stimulation of endothelial cells augments activation of the prekallikrein-high molecular weight kininogen complex: Implications for hereditary angioedema. [pubmed:27826093] |
| European Journal of Neuroscience | Urokinase receptor and tissue plasminogen activator as immediate‐early genes in pentylenetetrazole‐induced seizures in the mouse brain [Pubmed: 31587391] |
| Phytomedicine | Sodium aescinate significantly suppress postoperative peritoneal adhesion by inhibiting the RhoA/ROCK signaling pathway [Pubmed: 32120245] |
| Sci Rep | Fibroblast growth factor-21 as a novel metabolic factor for regulating thrombotic homeostasis [Pubmed:35013379] |
留言咨詢
